Spiderwort
Ottawa
About Spiderwort
Spiderwort is developing a novel biomaterial that will offer new avenues in regenerative medicine. We are using plant derived cellulose to create a variety of scaffold architectures. Currently, we are in the pre-clinical stage of this product and our promising results demonstrate that this new biomaterial is highly biocompatible and induce angiogenesis (blood vessel generation inside the scaffold).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $16.1M
- Funding stage: Early Stage Venture
- Last round: Non-Equity Assistance (Jun 2023)
- Website: spiderwortbio.com
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/spiderwort-77894 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.